PANAVAX
Sanofi Pasteur
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85184872 |
| Registration Number | 4113833 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Mark I. Peroff |
| Attorney Name | Mark I. Peroff |
| Attorney Docket Number | 311459.30492 |
| Law Office Assigned | M70 |
| Employee Name | BURNS, ELLEN FERRER |
Timeline
| 2010-11-24 | Application Filed |
| 2012-01-03 | Published for Opposition |
| 2012-03-20 | Location: PUBLICATION AND ISSUE SECTION |
| 2012-03-20 | Trademark Registered |
| 2018-10-26 | Cancelled |
| 2018-10-26 | Status: Dead/Cancelled |
| 2018-12-04 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Sanofi Pasteur |
| Entity Statement | société anonyme (sa) |
| Address | 2 Avenue Pont Pasteur Lyon FR 69007 |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Human vaccine against flu |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-11-27 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-11-30 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2011-03-03 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2011-03-10 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2011-03-10 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2011-03-10 | 6 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-09-07 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-09-07 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-09-07 | 9 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2011-09-25 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2011-09-25 | 11 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2011-09-25 | 12 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2011-10-21 | 13 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-10-21 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-10-21 | 15 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2011-11-03 | 16 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2011-11-03 | 17 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2011-11-03 | 18 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2011-11-03 | 19 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-11-03 | 20 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2011-11-28 | 21 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-12-01 | 22 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2011-12-14 | 23 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2012-01-03 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-01-03 | 25 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2012-03-20 | 26 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2012-06-07 | 27 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2017-03-20 | 28 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2018-10-26 | 29 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PANAVAX 85184872 4113833 Dead/Cancelled |
Sanofi Pasteur 2010-11-24 |
 PANAVAX 77042636 not registered Dead/Abandoned |
SANOFI PASTEUR 2006-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 